Clinical Trial Update: A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the cancer vaccine BNT116 in combination with cemiplimab for adults with advanced non-small cell lung cancer; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BNT116
• Cemiplimab (cemiplimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING